Oncosil Medical Ltd
ASX:OSL

Watchlist Manager
Oncosil Medical Ltd Logo
Oncosil Medical Ltd
ASX:OSL
Watchlist
Price: 0.005 AUD Market Closed
Updated: May 26, 2024

Operating Margin
Oncosil Medical Ltd

-3 248%
Current
-1 464%
Average
2.9%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-3 248%
=
Operating Profit
-11.5m
/
Revenue
355.3k

Operating Margin Across Competitors

Country Company Market Cap Operating
Margin
AU
Oncosil Medical Ltd
ASX:OSL
14.8m AUD
-3 248%
US
Thermo Fisher Scientific Inc
NYSE:TMO
222.9B USD
17%
US
Danaher Corp
NYSE:DHR
194.6B USD
22%
US
Agilent Technologies Inc
NYSE:A
44.1B USD
19%
US
IQVIA Holdings Inc
NYSE:IQV
41.7B USD
14%
CH
Lonza Group AG
SIX:LONN
37.2B CHF
20%
KR
Samsung Biologics Co Ltd
KRX:207940
53.5T KRW
29%
US
Mettler-Toledo International Inc
NYSE:MTD
31.6B USD
29%
IE
ICON PLC
NASDAQ:ICLR
26.5B USD
13%
US
West Pharmaceutical Services Inc
NYSE:WST
24.2B USD
23%
US
Waters Corp
NYSE:WAT
20B USD
27%
Oncosil Medical Ltd
ASX:OSL
Country AU
Market Cap 14.8m AUD
Operating Margin
-3 248%
Thermo Fisher Scientific Inc
NYSE:TMO
Country US
Market Cap 222.9B USD
Operating Margin
17%
Danaher Corp
NYSE:DHR
Country US
Market Cap 194.6B USD
Operating Margin
22%
Agilent Technologies Inc
NYSE:A
Country US
Market Cap 44.1B USD
Operating Margin
19%
IQVIA Holdings Inc
NYSE:IQV
Country US
Market Cap 41.7B USD
Operating Margin
14%
Lonza Group AG
SIX:LONN
Country CH
Market Cap 37.2B CHF
Operating Margin
20%
Samsung Biologics Co Ltd
KRX:207940
Country KR
Market Cap 53.5T KRW
Operating Margin
29%
Mettler-Toledo International Inc
NYSE:MTD
Country US
Market Cap 31.6B USD
Operating Margin
29%
ICON PLC
NASDAQ:ICLR
Country IE
Market Cap 26.5B USD
Operating Margin
13%
West Pharmaceutical Services Inc
NYSE:WST
Country US
Market Cap 24.2B USD
Operating Margin
23%
Waters Corp
NYSE:WAT
Country US
Market Cap 20B USD
Operating Margin
27%

Profitability Report

View the profitability report to see the full profitability analysis for Oncosil Medical Ltd.

Full Profitability Report

See Also

Summary
OSL intrinsic value, competitors valuation, and company profile.
DCF Valuation
OSL stock valuation using Discount Cash Flow valuation method.
Relative Valuation
OSL stock valuation using valuation multiples.
Wall Street Estimates
OSL price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
OSL stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-3 248%
=
Operating Profit
-11.5m
/
Revenue
355.3k
What is the Operating Margin of Oncosil Medical Ltd?

Based on Oncosil Medical Ltd's most recent financial statements, the company has Operating Margin of -3 248%.

ALPHA SPREAD
Join more than 140,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.